Related Experiment Video
Updated: Aug 15, 2026

Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Poorly absorbed antibiotics for the treatment of traveler's diarrhea
1Department of International Health, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA. david.taylor@salix.com
Abstract:
This article describes the use of poorly absorbed antibiotics for the treatment of traveler's diarrhea. Poorly absorbed oral antibiotics can deliver high concentrations of drug to the site of enteric infection with minimal risk of systemic adverse effects, toxicity, and drug interactions. Compared with systemically absorbed oral antibiotics, poorly absorbed oral antibiotics may be less associated with the pressure that leads to the development of bacterial resistance, because they do not affect bacteria outside the gastrointestinal tract. In clinical studies, poorly absorbed oral antibiotics, including aztreonam, bicozamycin, and rifaximin, were more effective than and as well tolerated as placebo; in particular, rifaximin was as effective as oral ciprofloxacin in reducing the duration of illness in traveler's diarrhea. More research is warranted to delineate the effects of poorly absorbed antibiotics in invasive infection and to assess the potential for the development of bacterial resistance.
Insights
Poorly absorbed antibiotics effectively treat traveler's diarrhea with fewer side effects and less risk of resistance. Rifaximin showed comparable efficacy to ciprofloxacin in clinical studies.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Background:
- Traveler's diarrhea (TD) is a common illness caused by enteric pathogens.
- Systemically absorbed antibiotics for TD carry risks of adverse effects and resistance development.
- Poorly absorbed oral antibiotics offer targeted gastrointestinal delivery with reduced systemic exposure.
Purpose of the Study:
- To review the efficacy and safety of poorly absorbed oral antibiotics for traveler's diarrhea.
- To compare the impact of poorly absorbed antibiotics on bacterial resistance compared to systemically absorbed agents.
Main Methods:
- Literature review of clinical studies on poorly absorbed oral antibiotics for TD.
- Analysis of antibiotic efficacy, tolerability, and potential for resistance development.
Main Results:
- Poorly absorbed antibiotics deliver high drug concentrations to the gut with minimal systemic effects.
- Agents like aztreonam, bicozamycin, and rifaximin demonstrated efficacy and good tolerability.
- Rifaximin was found to be as effective as ciprofloxacin in shortening TD illness duration.
Conclusions:
- Poorly absorbed oral antibiotics are a viable treatment option for traveler's diarrhea.
- These agents may pose a lower risk for promoting bacterial resistance.
- Further research is needed for invasive infections and comprehensive resistance assessment.
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drug Absorption: Factors Affecting GI Absorption
In...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Constipation-Predominant IBS
